Tuesday, July 23, 2013

Cardiovascular Monitoring & Diagnostic Devices Market Research Report Published By Transparency Market Research

Transparency Market Research
Market Research Reports : Transparency Market Research published new market report “Cardiovascular Monitoring & Diagnostic Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2011 – 2016”global cardiovascular monitoring & diagnostic devices market is estimated to be USD 797million in 2011 and expected to reach USD 1.3 billion in 2016 at a CAGR of 8.8% over the period 2010 to 2016. The ECG Monitoring Equipments segment is the leading market contributor with a share of around 51% in 2010.
 Cardiovascular Diseases (CVDs) are the largest cause of deaths globally, around 17.3 million people died from cardiovascular diseases in 2008. This amounts to 30% of all deaths. Of these deaths, an estimated 7.3 million were due to coronary heart disease and 6.2 million were due to stroke. Low- and middle-income countries are the largest affectedwith CVDs. An estimated 80% of CVD deaths take place in low- and middle-income countries. By 2030, almost 23.6 million people will die from CVDs, mainly from heart disease and stroke and are projected to be the single leading causes of death.
With the number of people suffering from cardiovascular diseases and the condition upswingsglobally, the demand for cardiovascular devices is growing.Around 30 million people are severely affected by cardiovascular diseases every year. A considerable market growth is provided in the stress testing systems and diagnostics all over the world by the emerging markets.The overall sales in 2009 was USD 34.9 billion as compared to the projected sale for 2010, estimated to be USD 36.2 billion at a compound annual growth rate of 3.6% in the global market for cardiovascular devices. There are two sub-segments accounting for the high demand—cardiac rhythm management and cardiovascular monitoring and diagnostic devices.
In 2009, the sales in diagnostic cardiovascular devices amounted to USD 11.1 billion, and in 2015, is estimated to reach USD 15.5 billion with a CAGR of 5.7% The U.S. represents the largest market in the worldwide cardiovascular disease market and Europe represents the second largest market, followed by Japan.The global Cardiovascular Monitoring and Diagnostic (CMD) devices marketis estimated to reach USD 1.3 billion in 2016, growing at a CAGR of 8.8% during 2010 – 2016.This market comprises of Electrocardiograph (ECG) monitoring equipment, ECG stress testing systems, Holter monitoring systems, ECG data monitoring systems, event monitoring systems, cardiovascular monitoring and diagnostic devices and cardiopulmonary stress testing systems. The largest segment growing at 10.7% over the period 2010 – 2016 and valued at USD 410.5 million in 2010 was the ECG monitoring equipment.
GE Healthcare, Philips Healthcare, Nihon Kohden, Cardiac Science Corp (now OptoCircuits) and Schiller AG are the leading companies in the global Cardiovascular Monitoring and Diagnostic devices market, with a combined share of more than 60%.
  • Scope and Overview
The objective of the study on “Global Cardiovascular Monitoring & Diagnostic Devices Market” is to gain detailed market insights for cardiovascular monitoring & diagnostic devicesused to treat CVDs in developing economies where the reported CVD incidence is very high and also in developed economies where advanced technologies are being rapidly implemented. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share.The report also covers the strategies followed by Global Cardiovascular Monitoring & Diagnostic Devices Market” players.
Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. It also includes the devices such as interventional cardiology, cardiac rhythm management, cardiac assist devices, peripheral vascular devices, cardiac surgery, devices used to monitor cardiac events and cardiac prosthetic devices to record the electrophysiological impulses of the heart and to analyze and diagnose any abnormality related to the cardiac function.

Cardiovascular Monitoring and Diagnostic devices are used to detect and provide feedback of abnormal episodes of electrical functioning of the heart. The Cardiovascular  Monitoring & Diagnostic devices include Holter and event recorders, ECG recorders and  ECG stress testing.

This report analyses the Cardiovascular Monitoring and Diagnostic devices into four sub- categories, which includes:
  • ECG monitoring equipment is used to record the Electrocardiogram, ECG which are the intrinsic electrical signals generated in the heart.
  • ECG stress test or Tread Mill Test (TMT) is a diagnostic device used to record the ECG by subjecting the heart to excessive workload. These systems measure the performance of the heart at various stress levels and help physicians in disease diagnosis and deciding treatment protocol.
  • Event monitors or recorders are devices used to record only the abnormal events of the ECG over an extended period of time.
  • Holter monitors are devices used to record the ECG for a 24-hour period and to identify abnormal episodes of the ECG.


Post a Comment